Article ID Journal Published Year Pages File Type
6099286 Journal of Crohn's and Colitis 2014 9 Pages PDF
Abstract
Infliximab treatment has beneficial clinical effect which is confirmed by decrease of PCDAI and increase of IMPACT-III. Autoregressive regression analysis showed regression relation between IMPACT-III and PCDAI and laboratory parameters.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , , , , , , , ,